Status:
COMPLETED
Immunity Against AAV in Crigler Najjar Patient
Lead Sponsor:
Genethon
Conditions:
Crigler Najjar Syndrome
Eligibility:
All Genders
Brief Summary
The proposed research protocol aims at addressing these points by pre-screening CN patients for their AAV serology in link with their medical history and current medical status. A first objective is t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- The patient has a Crigler-Najjar syndrome
- The molecular diagnosis has been confirmed by UGT1A1 gene DNA sequencing
- Exclusion criteria:
- The patient is liver transplanted
- The patient is suffering from severe associated pathologies precluding further enrolment in a future interventional clinical study
Exclusion
Key Trial Info
Start Date :
November 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT02302690
Start Date
November 1 2014
End Date
June 1 2017
Last Update
December 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Antoine Béclère
Clamart, France, 92141